Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Cannabidiol for Pediatric Epilepsy (Compassionate Use)

View source ↗

Summary

Cannabidiol was used under a compassionate-use program for children with refractory epilepsy, but the trial NCT02556008 is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Refractory Childhood Epilepsy | Status: NO_LONGER_AVAILABLE